Neuraxis
NRXS
10 hedge funds and large institutions have $308K invested in Neuraxis in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
33% more capital invested
Capital invested by funds: $233K → $308K (+$75.7K)
25% more funds holding
Funds holding: 8 → 10 (+2)
0.26% more ownership
Funds ownership: 1.41% → 1.67% (+0.26%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$41.4K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$37.7K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$29.2K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.15K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$137 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$22 |
NRXS Hedge Fund Activity: Q2 2024 in Review
10 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Neuraxis (NRXS) for Q2 2024, worth a combined $308K — up 33% from $233K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new NRXS positions and 1 closed out — a net gain of 2 holders — while 4 added to existing stakes and 0 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $41.4K. The largest seller was Wells Fargo, exiting entirely with an estimated $22 sold.
- 10 institutional investors held Neuraxis (NRXS) as of Q2 2024, up from 8 in Q1 2024.
- Funds reported $308K of Neuraxis stock for Q2 2024, up 33% quarter-over-quarter.
- 3 funds opened new Neuraxis positions in Q2 2024 and 1 closed out, a net change of +2 holders.
- The largest Neuraxis buyer in Q2 2024 was Citadel Advisors, an estimated $41.4K added.
- The largest Neuraxis seller in Q2 2024 was Wells Fargo, an estimated $22 sold.
Based on aggregated 13F filings for Q2 2024.